AIC
IMGN

Ameritas Investment Company’s Immunogen Inc IMGN Stock Holding History

Ameritas Investment Company’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-220
Closed -$1K – 1683
2020
Q1 		$1K Buy
+220
New +$962 ﹤0.01% 1720
2019
Q4 		– Sell
-220
Closed -$1K – 1581
2019
Q3 		$1K Buy
+220
New +$584 ﹤0.01% 1606
2019
Q1 		– Sell
-79
Closed – – 1853
2018
Q4 		$0 Buy
+79
New +$479 ﹤0.01% 1587

Other funds holding IMGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ameritas Investment Company's IMGN Position: Q2 2020 in Review

Ameritas Investment Company sold out of Immunogen Inc (IMGN) in Q2 2020, closing a stake of 220 shares — an estimated $1K sold.

Ameritas Investment Company first reported a position in IMGN in Q4 2018 and held it in 3 quarters. The position peaked at $1K in Q1 2020. 189 funds tracked by Wall St. Rank hold IMGN as of Q2 2020.

  • Ameritas Investment Company reported no remaining Immunogen Inc position as of Q2 2020 after selling out during the quarter.
  • Ameritas Investment Company sold 220 Immunogen Inc shares in Q2 2020, an estimated $1K.
  • Ameritas Investment Company first reported a position in Immunogen Inc in Q4 2018 and held it in 3 quarters.
  • Ameritas Investment Company's Immunogen Inc position peaked at $1K in Q1 2020.
  • 189 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2020.

Based on Ameritas Investment Company's 13F filing for Q2 2020, filed 14 Aug 2020.